GladysIRodriguezMD

PubMed

• 1 citations
  ASCO Policy Statement on Biosimilar and Interchangeable Products in Oncology.
  Gladys Rodriguez, Joan Mancuso, Gary H Lyman, Fatima Cardoso, Zeina Nahleh, Julie M Vose, Julie R Gralow, Michael Francisco, Shimere Sherwood> ;JCO Oncology Practice. 2023 Jul 1
• A Global Approach to Cancer Equity in the Hispanic/Latinx Population.
  Sybil R Green, Gladys Rodriguez, Enrique Soto-Perez-de-Celis, Everett E Vokes> ;JCO Oncology Practice. 2022 May 1
• 1 citations
  Dónde Están? Latinx/Hispanic Representation in the Oncology Workforce: Present and Future.
  Narjust Duma, Ana I Velazquez, Idalid Franco, Lauren Kiel, Laura A Levit, Caroline Schenkel, Kelsey Kirkwood, Sybil Green, Gladys Rodriguez> ;JCO Oncology Practice. 2022 May 1
• 58 citations
  American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care.
  Nathan A. Pennell, Melissa S. Dillmon, Laura A. Levit, E. Allyn Moushey, Ajjai Alva, Sibel Blau, Timothy L. Cannon, Natalie R. Dickson, Maximilian Diehn, Mithat Gonen,...> ;Journal of Clinical Oncology. 2021 Jan 10
• 17 citations
  TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer
  Denise A. Yardley, Edward Arrowsmith, Brooke R. Daniel, Janice F. Eakle, Adam Brufsky, David Drosick, Fred J. Kudrik, Linda D. Bosserman, Mark Keaton, Sharon A. Goble,...> ;Breast Cancer Research and Treatment. 2017 May 15
• 34 citations
  American Society of Clinical Oncology Strategic Plan for Increasing Racial and Ethnic Diversity in the Oncology Workforce
  Karen M. Winkfield, Christopher R. Flowers, Jyoti D. Patel, Gladys Rodriguez, Patricia A. Robinson, Amit Agarwal, Lori J. Pierce, Otis W. Brawley, Edith P. Mitchell, K...> ;Journal of Clinical Oncology. 2017 May 1
• 18 citations
  Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer
  Linda T. Vahdat, Rachel M. Layman, Denise A. Yardley, William J. Gradishar, Mohamad Adham Salkeni, Anil A. Joy, Agustin A. Garcia, Patrick J. Ward, James Khatcheressia...> ;The Oncologist. 2017 Mar 1
• 352 citations
  Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled,...
  A. Chan, Suzette Delaloge, Frankie A. Holmes, Beverly Moy, Hiroji Iwata, Vernon Harvey, Nicholas J. Robert, Tajana Silovski, Erhan Gokmen, Gunter von Minckwitz, Bent E...> ;The Lancet. Oncology. 2016 Mar 1
• 5 citations
  Pharmacogenomic diversity of tamoxifen metabolites and estrogen receptor genes in Hispanics and non-Hispanic whites with breast cancer.
  Leticia Batista Azevedo Rangel, Jodi L. Taraba, Christopher R. Frei, Lon Smith, Gladys Rodriguez, John G. Kuhn> ;Breast Cancer Research and Treatment. 2014 Nov 14
• 2 citations
  Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects wi...
  Sara A. Hurvitz, Linda D. Bosserman, David Chan, Christopher T Hagenstad, Frederick C Kass, Frederick P. Smith, Gladys Rodriguez, Barrett H Childs, Dennis J. Slamon> ;Springerplus. 2014 May 12
• 226 citations
  Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase ...
  Giorgio V. Scagliotti, Vera Hirsh, Salvatore Siena, David H. Henry, Penella J. Woll, Christian Manegold, Philippe Solal-Celigny, Gladys Rodriguez, Maciej Krzakowski, N...> ;Journal of Thoracic Oncology. 2012 Dec 1
• 40 citations
  Carcinoma of Unknown Primary Site: Sequential Treatment with Paclitaxel/Carboplatin/Etoposide and Gemcitabine/Irinotecan: A Minnie Pearl Cancer Research Network Phase ...
  F. Anthony Greco, Gladys Rodriguez, Don W. Shaffer, Robert C. Hermann, Sharlene Litchy, Denise A. Yardley, Howard A. Burris, Lisa H. Morrissey, Joan B. Erland, John D....> ;The Oncologist. 2004 Nov 1
• Weekly paclitaxel/estramustine phosphate plus carboplatin administered either weekly or every 4 weeks in the treatment of hormone refractory prostate cancer (HRPC): A ...
  Meluch AA, Greco FA, Burris HA, Erland JB, Khan RA, Rodriguez GI, Gandhi JG, Hainsworth JD> ;J. Clin. Oncol.. 2004-07-15
• 27 citations
  First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: phase II trial.
  John D. Hainsworth, Sharlene Litchy, M. Ray Lamb, Gladys Rodriguez, Jr. Carroll Scroggin, F. Anthony Greco> ;Clinical Lymphoma. 2003 Jun 1
• 10 citations
  Phase I Clinical Trials of Tezacitabine [(E)-2′-Deoxy-2′-(fluoromethylene)cytidine] in Patients with Refractory Solid Tumors
  Gladys Rodriguez, Richard E. Jones, Elaine K. Orenberg, Maxine L. Stoltz, Donald J. Brooks> ;Clinical Cancer Research. 2002 Sep 1
• 36 citations
  Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks
  Mace L. Rothenberg, J. G. Kuhn, L. J. Schaaf, G. I. Rodriguez, S. G. Eckhardt, Miguel A. Villalona-Calero, David Rinaldi, Lisa A. Hammond, Stephanie Hodges, Abhishek S...> ;Annals of Oncology. 2001 Nov 1
• A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer.
  Ganly I, Kirn D, Eckhardt G, Rodriguez GI, Soutar DS, Otto R, Robertson AG, Park O, Gulley ML, Heise C, Von Hoff DD, Kaye SB, Eckhardt SG> ;Clin. Cancer Res.. 2000-03-01
• 24 citations
  Phase I and pharmacologic study of PN401 and fluorouracil in patients with advanced solid malignancies
  Manuel Hidalgo, Miguel A. Villalona-Calero, S. Gail Eckhardt, Ronald Drengler, Gladys Rodriguez, Lisa A. Hammond, Sami Diab, Geoffrey R. Weiss, Allison M. Garner, Eliz...> ;Journal of Clinical Oncology. 2000 Jan 1
• 153 citations
  A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation.
  David Rinaldi, John G. Kuhn, Howard A. Burris, F. Andrew Dorr, Gladys Rodriguez, S. Gail Eckhardt, Suzanne F. Jones, James R. Woodworth, Sharyn D. Baker, Connie Langle...> ;Cancer Chemotherapy and Pharmacology. 1999 Jan 1
• 30 citations
  Phase II trial of docetaxel for cholangiocarcinoma.
  Richard Pazdur, Melanie Royce, Gladys Rodriguez, David Rinaldi, Yehuda Z. Patt, Paulo M. Hoff, Howard A. Burris> ;American Journal of Clinical Oncology. 1999 Feb 1
• 78 citations
  Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors
  Ronald Drengler, John G. Kuhn, Larry J. Schaaf, Gladys Rodriguez, Miguel A. Villalona-Calero, Lisa A. Hammond, Joseph A. Stephenson, Stephanie Hodges, Maura Kraynak, B...> ;Journal of Clinical Oncology. 1999 Feb 1
• 4 citations
  A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumors.
  Sami Diab, Sharyn D. Baker, Amita S. Joshi, Howard A. Burris, Patrick W. Cobb, Miguel A. Villalona-Calero, S. Gail Eckhardt, Geoffrey R. Weiss, Gladys Rodriguez, Ronal...> ;Clinical Cancer Research. 1999 Feb 1
• A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (Hycamtin)
  Gerrits CJ, Schellens JH, Burris H, Eckardt JR, Planting AS, van der Burg ME, Rodriguez GI, Loos WJ, van Beurden V, Hudson I, Von Hoff DD, Verweij J> ;Clin. Cancer Res.. 1999-01-01
• 44 citations
  A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies.
  Manuel Hidalgo, G. I. Rodriguez, J. G. Kuhn, Thomas D. Brown, Geoffrey R. Weiss, J P MacGovren, D. D. Von Hoff, Eric K. Rowinsky> ;Clinical Cancer Research. 1998 Nov 1
• 2 citations
  A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusion
  Gladys Rodriguez, John G. Kuhn, Geoffrey R. Weiss, Pearl De La Cruz, Pamela New, Suzanne M. Fields, John R. Eckardt, Liz Campbell, Gary M. Clark, Susan G. Hilsenbeck, ...> ;Investigational New Drugs. 1998 Aug 28
• Join now to see all